IDEX Corporation 10-K Summary: Fiscal Year Ended December 31, 2002
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended December 31, 2002 for IDEX Corporation, a Delaware corporation headquartered in Northbrook, Illinois. IDEX manufactures engineered industrial products across three reportable segments: Pump Products Group, Dispensing Equipment Group, and Other Engineered Products Group. The Company operates approximately 3,900 employees globally and maintains a strategy of acquiring niche market leaders, holding number-one or number-two market share positions in its principal units.
Key Financial Metrics
Note: Specific consolidated revenue, net income, cash flow, and debt figures are incorporated by reference to the 2002 Annual Report and are not explicitly detailed in the provided text. The following segment contributions are available:
- Segment Sales Contribution (2002):
- Pump Products Group: 58% of total sales.
- Other Engineered Products Group: 23% of total sales.
- Dispensing Equipment Group: 19% of total sales.
- Segment Operating Income Contribution (2002):
- Pump Products Group: 62% of total operating income.
- Other Engineered Products Group: 22% of total operating income.
- Dispensing Equipment Group: 16% of total operating income.
- International Exposure: Significant portion of sales are international, ranging from 20% to 65% depending on the specific business unit (e.g., Micropump at 65%, FAST at 95%).
- Restructuring Costs: In 2002, the Company recorded $1,328,000 in restructuring charges and expended $4,796,000 on previously accrued restructuring liabilities.
- Allowance for Doubtful Accounts: Ended the year at $3,089,000.
Material Changes and Acquisitions
The 2002 fiscal year was characterized by strategic acquisitions to expand market presence:
- Rheodyne L.P.: Acquired in July 2002; a leader in injectors and valves for analytical instrumentation.
- Wrightech Corporation: Acquired in October 2002; a manufacturer of stainless-steel positive displacement pumps for sanitary markets.
- Halox Technologies, Inc.: Acquired in April 2002; a manufacturer of point-of-use chlorine dioxide equipment.
- Operational Changes: The Company adjusted production schedules to maintain backlogs of approximately 1 to 1.5 months. Manufacturing capacity utilization ranged from 40% to 70% across facilities.
Outlook, Risks, and Contingencies
Legal Proceedings: IDEX and five subsidiaries are defendants in asbestos-related personal injury lawsuits. While components containing asbestos were acquired from third parties and not manufactured by IDEX, the Company notes that insurance has covered settlements and costs to date. However, future insurance availability is uncertain. No provision has been made in financial statements as the Company does not currently believe these claims will have a material adverse effect.
Market Risks: The Company operates in highly competitive markets, competing on performance, quality, service, and price. Principal competitors include divisions of Dover Corporation, United Technologies Corporation, and Illinois Tool Works Inc.
Management Commentary: Management attributes consistent financial performance to quality product design and successful integration of strategic acquisitions. The Company maintains good labor relations, with approximately 15% of employees represented by unions.
Investor Verification Checklist
- Verify the specific consolidated revenue, net income, and cash flow figures in the 2002 Annual Report to Shareholders (incorporated by reference in Items 6, 7, and 8).
- Review the 2003 Proxy Statement for details on executive compensation and security ownership.
- Monitor the status of asbestos-related litigation and the Company's ability to maintain insurance coverage for future claims.
- Assess the integration progress of 2002 acquisitions (Rheodyne, Wrightech, Halox) and their contribution to future earnings.
- Confirm the current status of manufacturing capacity utilization (reported as 40-70%) and its impact on fixed cost absorption.